EUVIMEDEUVIMED entdecken
Crossref

Effect of Acute Administration of Different Ketamine Doses on Anxiety and Metabolic Activity of the Amygdala in Rats

Manuel Alejandro Guevara, Sebastián Marcelo García Menéndez, Iker Barrutieta-Arberas, Esteban Alejandro Romanowicz, Adriana Inés Landa de Gargiulo, José Vicente Lafuente, Pascual Ángel Gargiulo

Neuropsychobiology · 2025

DOI: 10.1159/000547982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychobiology, 2025. Verfasst von Manuel Alejandro Guevara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuroscience and Experimental Psychology, Area of Pharmacology, Department of Pathology, Faculty of Medical Sciences, National Universi…. Hauptthemen laut MEDLINE: Ketamine, Amygdala, Anxiety, Excitatory Amino Acid Antagonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Anxiety has been described in the initial stages of schizophrenia and affective flattening in the chronic illness. The aetiology remains unknown. Ketamine, a non-competitive n-methyl-d-amino-aspartate acid receptor antagonist, is used in rats as a translational model of schizophrenia. A glutamate deficit within nucleus accumbens septi (NAS) afferent projections has been proposed to be involved in schizophrenia. The amygdala is related to memory, fear, and anxiety and is closely linked to the NAS. Here, we studied anxiety in male rats using the elevated plus maze (EPM) after receiving acute administration of different subanaesthetic doses of ketamine. The metabolic state of the amygdala was measured after ketamine treatment. The main aim of the present study was to compare the effect of different doses as emulating progressive stages of schizophrenia.

Methods

Classical anxiety parameters were observed during EPM experiments in rats with the low doses of ketamine. After this, amygdalas were randomly extracted and submitted to a test of redox cellular metabolic activity with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).

Results

Low doses (1.25 and 2.5 mg/kg) significantly decreased time spent in the open arm, time per entry, and open arm entries and increased time in the closed arms and grooming. These doses also decreased metabolic activity.

Conclusion

We conclude that the administration of subanaesthetic doses of ketamine exerts an acute anxiogenic effect in the plus maze test at the lower doses, accompanied by a decrease in amygdala metabolic activity, suggesting metabolic exhaustion. The higher doses reversed the anxiety parameters, suggesting an explanation of the opposite symptoms in schizophrenia progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineAmygdalaAnxietyExcitatory Amino Acid AntagonistsBehavior, AnimalAnimalsMaleRatsRats, WistarDose-Response Relationship, DrugSchizophreniaDisease Models, AnimalMaze Learning

Stichwörter der Autor:innen

AmygdalaAnxietyBrain metabolismKetaminePlus maze testSchizophrenia

Substanzen

KetamineExcitatory Amino Acid Antagonists

Autor:innen und Institutionen

  • Laboratory of Neuroscience and Experimental Psychology, Area of Pharmacology, Department of Pathology, Faculty of Medical Sciences, National University of Cuyo, CONICET, Mendoza, Argentina.
  • Laboratory of Clinical and Experimental Neuroscience. University of the Basque Country, Bilbao, Spain.
  • Los Andes Academy of Sciences (LAAS, ACLA), Latin American Technological Corporation Foundation (FUCOTEL), Mendoza, Argentina.
  • Laboratory of Neuroscience and Experimental Psychology, Area of Pharmacology, Department of Pathology, Faculty of Medical Sciences, National University of Cuyo, CONICET, Mendoza, Argentina, pagargiulo@hotmail.com.
  • Los Andes Academy of Sciences (LAAS, ACLA), Latin American Technological Corporation Foundation (FUCOTEL), Mendoza, Argentina, pagargiulo@hotmail.com.

Zitieren

APA

Guevara, M. A., García Menéndez, S. M., Barrutieta-Arberas, I., Romanowicz, E. A., Landa de Gargiulo, A. I., Lafuente, J. V., & Gargiulo, P. Á. (2025). Effect of Acute Administration of Different Ketamine Doses on Anxiety and Metabolic Activity of the Amygdala in Rats. Neuropsychobiology. https://doi.org/10.1159/000547982

Vancouver

Guevara MA, García Menéndez SM, Barrutieta-Arberas I, Romanowicz EA, Landa de Gargiulo AI, Lafuente JV, et al. Effect of Acute Administration of Different Ketamine Doses on Anxiety and Metabolic Activity of the Amygdala in Rats. Neuropsychobiology. 2025. doi:10.1159/000547982

BibTeX
@article{Guevara2025,
  author = {Guevara, Manuel Alejandro and García Menéndez, Sebastián Marcelo and Barrutieta-Arberas, Iker and Romanowicz, Esteban Alejandro and Landa de Gargiulo, Adriana Inés and Lafuente, José Vicente and Gargiulo, Pascual Ángel},
  title = {Effect of Acute Administration of Different Ketamine Doses on Anxiety and Metabolic Activity of the Amygdala in Rats},
  journal = {Neuropsychobiology},
  year = {2025},
  doi = {10.1159/000547982}
}
Kostenlos starten →